Literature DB >> 34951563

Depleting circ_0088364 restrained cell growth and motility of human hepatocellular carcinoma via circ_0088364-miR-1270-COL4A1 ceRNA pathway.

Kai Sun1, Haochen Wang1, Dongyuan Zhang1, Yupeng Li1, Lei Ren1.   

Abstract

Circular RNA hsa_circ_0088364 (circ_0088364) is a contributory factor in the malignancy of hepatocellular carcinoma (HCC). We aimed to elaborate its role and competing endogenous RNA (ceRNA) mechanism in HCC cell growth and motility. Expression of circ_0088364, microRNA (miR)-1270 and Collagen type IV alpha 1 chain (COL4A1) was measured by real-time quantitative PCR and Western blotting, and their relationships were determined by dual-luciferase reporter assay, RNA immunoprecipitation, biotinylated RNA pull-down, and Spearman's rank correlation analysis. Cellular programs were measured by cell counting kit-8 assay, flow cytometry and transwell assays, Western blotting, and xenograft experiment. Expression of circ_0088364 and COL4A1 was upregulated, and miR-1270 was downregulated in HCC patients' tumors; moreover, there were linear correlations among circ_0088364, miR-1270, and COL4A1 expression. Essentially, circ_0088364 and COL4A1 were ceRNAs for miR-1270 via target binding. In function, silencing circ_0088364 or upregulating miR-1270 could suppress cell proliferation, cell cycle entrance, transwell migration and invasion in Huh7 and HCCLM3 cells, as well as promote apoptosis rate. Moreover, above-mentioned effects were accompanied with reduced B-cell lymphoma (Bcl)-2, N-cadherin and Vimentin levels, and elevated Bcl-2-associated X protein (Bax) and E-cadherin levels. Contrarily, exhausting miR-1270 and restoring COL4A1 could severally abrogate the tumor-suppressive roles of circ_0088364 knockdown and miR-1270 overexpression in HCC cells in vitro. In vivo, silencing circ_0088364 retarded xenograft tumor growth in nude mice induced by Huh7 cells by upregulating miR-1270 and downregulating COL4A1. Blocking circ_0088364 suppressed HCC by inhibiting cell growth and motility via targeting miR-1270-COL4A1 axis.

Entities:  

Keywords:  COL4A1; Circ_0088364; HCC; miR-1270

Mesh:

Substances:

Year:  2021        PMID: 34951563      PMCID: PMC8855875          DOI: 10.1080/15384101.2021.2016196

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  31 in total

Review 1.  Circular RNAs in liver diseases: Mechanisms and therapeutic targets.

Authors:  Li-Yun Fu; Shu-Wei Wang; Meng-Yuan Hu; Zhen-Luo Jiang; Li-Li Shen; Yu-Ping Zhou; Jun-Ming Guo; Yao-Ren Hu
Journal:  Life Sci       Date:  2020-11-02       Impact factor: 5.037

Review 2.  Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role.

Authors:  Parisa Naeli; Mohammad Hossein Pourhanifeh; Mohammad Reza Karimzadeh; Zahra Shabaninejad; Ahmad Movahedpour; Hossein Tarrahimofrad; Hamid Reza Mirzaei; Hassan Hassani Bafrani; Amir Savardashtaki; Hamed Mirzaei; Michael R Hamblin
Journal:  Crit Rev Oncol Hematol       Date:  2019-12-20       Impact factor: 6.312

3.  Hsa-circRNA-103809 Promotes Hepatocellular Carcinoma Development via MicroRNA-1270/PLAG1 Like Zinc Finger 2 Axis.

Authors:  Yajuan Cao; Qingsong Tao; Xiaoming Kao; Xinhua Zhu
Journal:  Dig Dis Sci       Date:  2020-07-18       Impact factor: 3.199

4.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

5.  Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation.

Authors:  Chao Zhang; Hui Li; Wei Jiang; Xiaowei Zhang; Gang Li
Journal:  Oncotarget       Date:  2016-12-13

6.  Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer via miR-1270 Suppression.

Authors:  Zhao Zhao; Mei Ji; Qianqing Wang; Nannan He; Yue Li
Journal:  Mol Ther Nucleic Acids       Date:  2019-07-29       Impact factor: 8.886

7.  COL4A1 promotes the growth and metastasis of hepatocellular carcinoma cells by activating FAK-Src signaling.

Authors:  Ting Wang; Haojie Jin; Jingying Hu; Xi Li; Haoyu Ruan; Huili Xu; Lin Wei; Weihua Dong; Fei Teng; Jianren Gu; Wenxin Qin; Xiaoying Luo; Yujun Hao
Journal:  J Exp Clin Cancer Res       Date:  2020-08-03

8.  The Long Noncoding RNA ZFAS1 Potentiates the Development of Hepatocellular Carcinoma via the microRNA-624/MDK/ERK/JNK/P38 Signaling Pathway.

Authors:  Rui Duan; Caiyan Li; Fan Wang; Fei Han; Ling Zhu
Journal:  Onco Targets Ther       Date:  2020-05-19       Impact factor: 4.147

9.  CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression.

Authors:  Yang Su; Xiurui Lv; Wei Yin; Lingling Zhou; Yilin Hu; Ang Zhou; FuZhen Qi
Journal:  Aging (Albany NY)       Date:  2019-10-01       Impact factor: 5.682

10.  The correlation and role analysis of COL4A1 and COL4A2 in hepatocarcinogenesis.

Authors:  Yanli Liu; Jiaye Zhang; Yan Chen; Hasan Sohel; Xinrong Ke; Jingqi Chen; Yin-Xiong Li
Journal:  Aging (Albany NY)       Date:  2020-01-05       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.